Maynard Um
-
-
-
-
-
-
-
Earnings preview: Bernstein sees ‘clear potential for further upside’ in this stock
-
-
-
-
-
-
-
Lilly to file for next-gen obesity drug approval in early 2027
-
-
-
-
-
-
-
Eli Lilly (LLY) PT Raised to $1,385 at Bernstein SocGen Group
-
-
-
-
-
-
-
Abbvie (ABBV) PT Raised to $265 at Cantor Fitzgerald: Broadly Strong Q2 Results Expected
-
-
-
-
-
-
-
Sangamo files Chapter 11, agrees to sell assets to Lilly, Astellas
-
-
-
-
-
-
-
Lilly's Jaypirca reduces disease progression risk by 45% in CLL study
-
-
-
-
-
-
-
Eli Lilly reports positive results for obesity drug retatrutide trials
-
433,290 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

